Directors Reflect on How a Vaccine and the Election Will Shape the Coming Year
After the US presidential election and looking ahead to a new year, most companies are still wondering when the world will return to normal. News that a COVID-19 vaccine may soon be publicly available—both Pfizer and Moderna announced in November that their respective vaccines have proven to be 95 percent effective and are now awaiting federal approval—spurs hope that “normal,” or something near it, may be around the corner. Read the full article by NACD’s Mandy Wright here.
